Traditional Chinese Medicine for Complications in Critically Ill Patients

NCT05458687 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-07-14

No results posted yet for this study

Summary

The purpose of this study was to examine the impact of Chinese medicine on common problems in intensive care units.

Conditions

  • Critically Ill Patients

Interventions

OTHER

Chinese herbal medicine decoction、Acupuncture or Laser acupuncture pen treatment、Acupoint Tuina massage、Acupoint application、Nursing/Diet and health education and guidance

* Chinese herbal medicine decoction: prescribed three times a day, seven days a week, and lasts for up to one weeks. * Acupuncture or Laser acupuncture pen treatment: twice a week, once for 20 minutes,up to a total of one week. * Acupoint Tuina massage: once a day for up to 20 minutes each time, for up to a week. * Acupoint application of traditional Chinese herbal medicinal cake: Apply warm navel ointment in our hospital to CV 4 (Guanyuan) point every day, and remove after getting up the next day, seven days a week for up to one week. * Nursing and health education and guidance: teach the patients and their family members the matters needing attention in daily life. * Diet and health education:give personalized Traditional Chinese Medicine diet guidance and recommendations in accordance with Traditional Chinese Medicine physique syndrome.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2023-06-20
Completion
2023-06-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05458687 on ClinicalTrials.gov